Search results
2 days ago · Introduction. Atherosclerotic cardiovascular disease (ASCVD) affects >120 million people, or ∼2% of the global population. Coronary artery disease (CAD) comprises the bulk of ASCVD and is a leading cause of morbidity and mortality. 1 Due largely to more effective preventive interventions such as lipid-lowering therapy (LLT), rates of ASCVD in middle-aged and older adults are declining. 2 In ...
22 hours ago · This review examines the effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on different heart failure phenotypes with preserved ejection fraction (HFpEF). Traditional heart failure treatment modalities have shown limited success in improving outcomes for patients with HFpEF, but new evidence suggests that GLP-1RAs could be beneficial.
22 hours ago · Supported by grants from the National Cancer Institute of the National Institutes of Health (U10CA180888, U10CA180819, U10CA180821, U10CA180820, U10CA180863, and UG1CA189955); Bristol Myers Squibb ...
1 day ago · Cardiac rehabilitation (CR) is a multidisciplinary intervention program aimed at enhancing the physical, psychological, and social functioning of patients with cardiovascular disease. Although CR is cost-effective and reduces mortality and readmission ...
5 days ago · Across our health care system, we take pride in utilizing the most effective techniques and latest equipment to provide comprehensive cardiovascular and thoracic diagnostic testing to detect a variety of cardiovascular conditions and thoracic disorders.
1 day ago · Moderate to severe pain after cardiac surgery is relatively common, which increases the risk of postoperative cardiopulmonary complications and delays recovery. Opioids have been useful agents for postoperative pain control after cardiac surgery but are found to be associated with serious adverse effects. In this current era of fast track extubation and enhanced recovery, multimodal analgesia ...
5 days ago · Li K, Li B, Zhang D, Du T, Zhou H, Dai G, Yan Y, Gao N, Zhuang X, Liao X, et al. The translational landscape of human vascular smooth muscle cells identifies novel short open reading frame‐encoded peptide regulators for phenotype alteration. Cardiovasc Res. 2023;119:1763–1779.
